• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Email
  • Facebook
  • LinkedIn
  • Twitter
  • YouTube

International Alliance of ALS/MND Associations

  • Members' Login
  • Contact
  • Join the Alliance
  • Donate
  • What is ALS/MND
  • Find a Member Association
  • Support for PALS & CALS
    • Fundamental Rights for People with ALS/MND and Caregivers
    • Research
      • Voice Preservation
      • Open Science
      • Expanded Access
      • Understanding ALS/MND Research
      • Improving Regulatory Pathways
      • Right to Try
      • US FDA Orphan Drug Designation
      • Unproven (Off-Label) Treatments
      • Open Label Extension
    • Advocacy
      • Advocacy Toolkit
      • Emergency Preparedness Toolkit
      • Equitable Access to Therapies
      • Recommendations for Trial Sponsors
    • Clinical Care
      • Genetic Counselling & Testing
      • Mental Health Support
      • Nursing and Symptom Management
      • Nutrition and Swallowing
      • Occupational Therapy and Activities of Daily Living
      • Physiotherapy and Mobility
      • Respiratory Care
      • Speech Therapy and Communication
      • Support for Family & Caregivers
      • Technology
      • Global Clinic Locator
    • Drugs in Development
      • AB Science – Masitinib
      • BrainStorm Cell Therapeutics – NurOwn
      • Clene Nanomedicine – CNM-Au8
      • Collaborative Medicinal Development – CuATSM
      • ILB – Tikomed
      • Kadimastem – AstroRx
      • Mitsubishi Tanabe Pharma America – Oral Edaravone
      • Neuronata-R/Lenzumestrocel
      • NeuroSense – PrimeC
      • Neuvivo – NP001
      • Prilenia Therapeutics – Pridopidine
      • T Regulatory Cell Therapies
      • SOD1 Therapies & Trials
    • Approved Drugs
      • Neudexta
      • Radicava/Edaravone
      • Riluzole/Tiglutik
      • Tofersen/Qalsody
    • Drugs No Longer in Development
      • Amylyx – AMX0035
      • Collaborative Medicinal Development – CuATSM
      • Cytokinetics – Reldesemtiv
      • Orphazyme – Arimoclomol
      • TUDCA Trial
  • Support for Health Professionals
    • Breaking the News in ALS/MND
  • Events/Programs
    • Calendar of Events/Programs
    • Alliance Meeting
    • Allied Professionals Forum
    • Alliance Webinars
    • ALS/MND Connect
    • Global Day Calendar
    • March of Faces
    • Patient Fellows Program
    • International Symposium
  • About
    • Who We Are
    • Board of Trustees
    • Advisory Councils/Committees
      • Scientific Advisory Council
      • PALS and CALS Advisory Council
      • Innovation and Technology Council
      • Advocacy and Public Policy Forum
      • Research Directors Forum
      • Governance Committee
      • Finance Committee
    • Staff
    • History
    • Archives
      • Newsletters
      • Meetings
    • Awards
      • Student Innovation Award
      • Forbes Norris Award
      • Humanitarian Award
      • Allied Health Professional Award
  • Members
    • Member Registration
    • Forgot Password

Allied Professionals Forum

LOCATION UPDATE: Due to ongoing travel uncertainties to the U.S., our meetings will now take place in Toronto, Canada. We know this change may disrupt your plans and appreciate your understanding. We hope to see you there in person or virtually! 


Are you ready to be part of something bigger? The Allied Professionals Forum (APF) brings together healthcare professionals from around the world, including physiotherapists, respiratory therapists, nutritionists, speech-language pathologists, social workers and others working in the field of ALS/MND. With over 400 delegates attending from more than 40 countries, the APF provides the opportunity to engage in a truly global conversation on the challenges and advancements in ALS/MND care.

When: December 1-2, 2025
Where: Toronto, Canada and Virtual Platform
Program: See the preliminary program. 

To guarantee the lowest pricing (in-person – £325; virtual – £125), register now.

Call for Abstracts Open: Allied Professionals Forum & Poster Hall 

These events are an excellent opportunity for you to showcase innovative approaches, share practical insights, and highlight impactful work that improves the lives of people living with ALS/MND and their caregivers. We invite submissions in the following areas:

  • Care
  • Research
  • Education and information
  • Quality of life
  • Support
  • Genetics
  • Caregivers/Carers

We especially welcome abstracts that present new and practical approaches, applied research with real-world relevance, and data that reinforces or extends existing knowledge.

Deadline to submit: Monday, June 2

  • Submit your abstract for the Allied Professionals Forum.
  • Submit your abstract for the virtual Poster Hall.

If you are submitting to both events, please open each submission portal in incognito or private browsing mode to avoid technical issues.

  • On Windows: Ctrl + Shift + N
  • On Mac: Command + Shift + N

See the questions on the abstract application to prepare.

If you have any questions, reach out to Jessica Mabe, Programs Coordinator, at jessica.mabe@als-mnd.org.

Virtual Poster Hall

We’re launching our virtual Poster Hall on October 29, where you can browse posters from all over the world in dynamic online galleries with videos from the authors. Then on November 13, join us to talk with the poster authors and your peers. To meet the time zone needs of our diverse community, these discussions will be at 7:00 AM ET and 7:00 PM ET.

The virtual Poster Hall will then remain open until the close of the Allied Professionals Forum on December 2. 

The Poster Hall is free! If you’ve already registered for the Allied Professionals Forum, you’re Poster Hall ticket is included.

What Last Year’s Participants Had to Say

  • “First time at conference. Very worthwhile. Great speakers and range of topics.”
  • “This conference exceeded my expectations. The content was excellent, the format (everyone exposed to all the content) was unique and worked very well.”
  • “I did not expect this event to be as ‘personal’ as it was. I was very moved by some of the talks and it was wonderful to see so many caring professionals sitting alongside people with lived experience.”
  • “This was phenomenal! It was my first time attending this conference. I did so virtually. Your platform is amazing and made this a seamless experience. Thank you.”

You can also find a recap of the 2024 international meetings in our December newsletter. 

Virtual Poster Hall (pre-event)

The 2025 Poster Hall will be virtual and available in advance of the APF via the virtual event platform. The posters will be displayed in online galleries, with accompanying audio or video from their creators, to enhance the presentation of research.

When: Late October to early December, with virtual discussion forums in November
Where: Virtual Platform
Cost: Free (Please note that those attending the APF or Alliance Meeting are automatically registered for the Poster Hall.)

Coming soon! Submit Your Poster Abstract 

Do you have a virtual poster to share with the ALS/MND community? We’re looking to hear from you in the following areas:

  • Care
  • Research
  • Education and information
  • Quality of life
  • Support
  • Genetics
  • Caregivers/Carers

We encourage poster abstracts focused on approaches that are novel, practical and applicable, as well as studies presenting data that consolidate and/or extend current knowledge.

2025 Host Associations

 

 

 

Primary Sidebar

Events/Programs

  • Calendar of Events/Programs
  • Alliance Webinars
  • Alliance Meeting
  • Allied Professionals Forum
  • ALS/MND Connect
  • Global Day Calendar
  • March of Faces
  • International Symposium

  • Mahmood Anwar, UK

    Mahmood Anwar, UK

  • Steve Lufkin, USA

    Steve Lufkin, USA
    IMG_3993

  • Joyce Rusinak, Forbes Norris ALS Center, USA

    Joyce Rusinak, Forbes Norris ALS Center, USA

  • Enzo Maccarrone, AISLA ONLUS, Italy

    Enzo Maccarrone, AISLA ONLUS, Italy

  • Amparo Muriel Engativa, Colombia

    Amparo Muriel Engativa, Colombia

  • Steve

    Steve

  • Emilienne Verhaegen, ALS Liga Belgium, Diagnosed 2014

    Emilienne Verhaegen, ALS Liga Belgium, Diagnosed 2014

  • Brigitte Wernli,  Association ALS Switzerland,  Diagnosed 2014

    Brigitte Wernli, Association ALS Switzerland, Diagnosed 2014

  • Roxana Canova, Diagnosed 2012 ,  Asociación ELA Argentina

    Roxana Canova, Diagnosed 2012 , Asociación ELA Argentina

  • Norm MacIsaac,  ALS Society of Canada,  ALS Society of Quebec,  Diagnosed 2014

    Norm MacIsaac, ALS Society of Canada, ALS Society of Quebec, Diagnosed 2014

  • Sam Hayden-Harler, Motor Neurone Disease (MND) Association, UK

    Sam Hayden-Harler, Motor Neurone Disease (MND) Association, UK

  • Monica Soriano, Diagnosed 2011 ,  Asociación ELA , Argentina

    Monica Soriano, Diagnosed 2011 , Asociación ELA , Argentina

  • Nicholas (Nic) Bowman, MND Association of South Africa,  Diagnosed 2016,  Australia

    Nicholas (Nic) Bowman, MND Association of South Africa, Diagnosed 2016, Australia

  • Jason Goodman, Les Turner ALS Foundation, USA

    Jason Goodman, Les Turner ALS Foundation, USA

  • Francisco Perez Palop, Diagnosed 2013 , FUNDELA, Spain

    Francisco Perez Palop, Diagnosed 2013 , FUNDELA, Spain

  • Orlando Ruiz, Diagnosed 2001,  ACELA, Colombia

    Orlando Ruiz, Diagnosed 2001, ACELA, Colombia

  • Ana Lilia RodriguezApoyo Integral Gila A.C., Diagnosed 2018, Mexico

    Ana Lilia RodriguezApoyo Integral Gila A.C., Diagnosed 2018, Mexico

  • Jean

    Jean
    jean

  • Maurice LeClerc, ALS Canada

    Maurice LeClerc, ALS Canada

  • John and Loretta Russo, USA

    John and Loretta Russo, USA
    final3878

  • Phil Rossall, MND-Association, UK

    Phil Rossall, MND-Association, UK

  • Sébastien Batiot, Diagnosed 2012 , ARSLA, France

    Sébastien Batiot, Diagnosed 2012 , ARSLA, France

  • Alejandro Aquino, Diagnosed 2011 , Asociación ELA Argentina

    Alejandro Aquino, Diagnosed 2011 , Asociación ELA Argentina

  • Lucy Lintott, Diagnosed 2013 , MND Scotland, UK

    Lucy Lintott, Diagnosed 2013 , MND Scotland, UK

  • Juvenal Bayona Romero

    Juvenal Bayona Romero

  • Fabio Correia

    Fabio Correia

  • Marcelo Farinelli, Diagnosed 2006, ABrELA, Brazil

    Marcelo Farinelli, Diagnosed 2006, ABrELA, Brazil

  • Anita Forte, Les Turner ALS Foundation, USA

    Anita Forte, Les Turner ALS Foundation, USA

  • Chen Chun-Chin

    Chen Chun-Chin

  • Willi Klein

    Willi Klein

  • Jan Zuring, Diagnosed 2010 , The Netherlands

    Jan Zuring, Diagnosed 2010 , The Netherlands

  • Shay Rishoni, Diagnosed 2011 - Prize4Life, Israel

    Shay Rishoni, Diagnosed 2011 – Prize4Life, Israel

  • Ailsa Malcolm-Hutton, Diagnosed 2013,  MND Association of England, Wales and N Ireland

    Ailsa Malcolm-Hutton, Diagnosed 2013, MND Association of England, Wales and N Ireland

  • Jack Buzby, USA

    Jack Buzby, USA

  • Horacio Fritzer, Argentina

    Horacio Fritzer, Argentina

  • Mauril Belanger

    Mauril Belanger

  • Steven Gallagher, Canada

    Steven Gallagher, Canada

  • MNDaSG Group PALS & CALS, Motor Neurone Disease Association, Singapore (MNDaSG)

    MNDaSG Group PALS & CALS, Motor Neurone Disease Association, Singapore (MNDaSG)

  • Marco Antonio Alvarez Mercado, Mexico

    Marco Antonio Alvarez Mercado, Mexico

  • Natalya Rybakova, Russian Charity ALS Foundation

    Natalya Rybakova, Russian Charity ALS Foundation

  • Jose Rivero Muñoz, Diagnosed 2015, FYADENMAC, Mexico

    Jose Rivero Muñoz, Diagnosed 2015, FYADENMAC, Mexico

  • Bjarne Hytjanstorp, ALS Norge, Norway

    Bjarne Hytjanstorp, ALS Norge, Norway

  • Carlos Alberto Arango, Colombia

    Carlos Alberto Arango, Colombia

  • Rosie Riley, Les Turner ALS Foundation, USA

    Rosie Riley, Les Turner ALS Foundation, USA

  • Angie Bordaen, Diagnosed 2014,  ALS Liga België, Belgium

    Angie Bordaen, Diagnosed 2014, ALS Liga België, Belgium

  • Maria Lucia Wood Saldanha, Associação Pró-Cura da ELA, Brazil

    Maria Lucia Wood Saldanha, Associação Pró-Cura da ELA, Brazil

  • Liz Ogg, Diagnosed 2013 , MND Scotland, UK

    Liz Ogg, Diagnosed 2013 , MND Scotland, UK

  • Michel Perrozzo, ARSLA, Diagnosed 2015, France

    Michel Perrozzo, ARSLA, Diagnosed 2015, France

  • Ada Garrido Benavidez, Diagnosed 2016,  FYADENMAC, Mexico

    Ada Garrido Benavidez, Diagnosed 2016, FYADENMAC, Mexico

  • Erwin Coppejans, Diagnosed 2007 , ALS Liga België, Belgium

    Erwin Coppejans, Diagnosed 2007 , ALS Liga België, Belgium

Learn more about the March of Faces

Latest Tweets

  • Just now

Footer

Subscribe to our Bi-Monthly Newsletter

Sign up to receive updates and to hear what's going on in the International Alliance of ALS/MND Associations.

"*" indicates required fields

 
This field is for validation purposes and should be left unchanged.
  • Email
  • Facebook
  • LinkedIn
  • Twitter
  • YouTube
Return to top of page

Contact | Disclaimer | Privacy Notice & Cookies | Sitemap

Copyright © 2025 The International Alliance of ALS/MND Associations. All rights reserved.


Registered in England: Charity Number 1079504 · Site built by graphics.coop · Powered by WordPress · Members' login